ClinicalTrials.Veeva

Menu

Super-Bolus: Effects on Postprandial Glycemia After High Glycemic Index Meal

M

Medical University of Warsaw

Status and phase

Completed
Phase 4

Conditions

Diabetes Mellitus, Type 1

Treatments

Drug: Insulin Aspart
Drug: Insulin Glulisine
Drug: Insulin Lispro

Study type

Interventional

Funder types

Other

Identifiers

NCT04019821
SuperBolus

Details and patient eligibility

About

The aim of this study is to determine whether Super-Bolus is more effective in postprandial glycemic control than Normal-Bolus after the high glycemic index (H-GI) meal in children with type 1 diabetes (T1DM) treated with insulin pump (continuous subcutaneous insulin infusion, CSII).

Enrollment

72 patients

Sex

All

Ages

10 to 18 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • duration of type 1 diabetes longer than 12months,
  • insulin pump therapy longer than 3 months,
  • written informed consent to participate in the study signed by parents (and patient older than 16 years).

Exclusion criteria

  • celiac disease,
  • diabetes related complications (e.g. nephropathy),
  • BMI at or above the 95th percentile and at or below 3rd percentiles for children and teenagers of the same age and sex,
  • withdrawal of consent to participate in the study,
  • comorbid conditions and treatment which could significantly affect glycemic values in the researchers' opinion.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Double Blind

72 participants in 2 patient groups

Normal Bolus
Active Comparator group
Description:
Pre-breakfast insulin will be given as a Normal Bolus 15 minutes before the high-glycemic index meal (cornflakes and milk). The Normal Bolus will be calculated based on individual insulin-to-carbohydrate ratio (ICR).
Treatment:
Drug: Insulin Lispro
Drug: Insulin Glulisine
Drug: Insulin Aspart
Super Bolus
Experimental group
Description:
Pre-breakfast insulin will be given as a Super Bolus 15 minutes before the high-glycemic index meal (cornflakes and milk). The Super Bolus will be calculated based on individual ICR increased to 150% and basal insulin will be suspended for 2 hours at the same time.
Treatment:
Drug: Insulin Lispro
Drug: Insulin Glulisine
Drug: Insulin Aspart

Trial contacts and locations

1

Loading...

Central trial contact

Emilia Kowalczyk; Agnieszka Szypowska, Professor

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems